Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme.

× No keyword cloud information.

53 in total

1. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors: G A Kune; S Kune; L F Watson
Journal: Cancer Res Date: 1988-08-01 Impact factor: 12.701

2. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.

Authors:
Journal: N Engl J Med Date: 1990-03-22 Impact factor: 91.245

3. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors: D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal: J Biol Chem Date: 1991-07-15 Impact factor: 5.157

4. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.

Authors: P Patrignani; P Filabozzi; C Patrono
Journal: J Clin Invest Date: 1982-06 Impact factor: 14.808

5. Human cyclooxygenase-2 cDNA.

Authors: T Hla; K Neilson
Journal: Proc Natl Acad Sci U S A Date: 1992-08-15 Impact factor: 11.205

6. Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors: E Kopp; S Ghosh
Journal: Science Date: 1994-08-12 Impact factor: 47.728

Review 7. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors: S C Cannegieter; F R Rosendaal; E Briët
Journal: Circulation Date: 1994-02 Impact factor: 29.690

8. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Authors: R J Clarke; G Mayo; P Price; G A FitzGerald
Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245

9. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

Authors: L C Wallentin
Journal: J Am Coll Cardiol Date: 1991-12 Impact factor: 24.094

10. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).

Authors: P W Serruys; W Rutsch; G R Heyndrickx; N Danchin; E G Mast; W Wijns; B J Rensing; J Vos; J Stibbe
Journal: Circulation Date: 1991-10 Impact factor: 29.690

4 in total

1. Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Authors: Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal: Bioorg Med Chem Date: 2012-10-23 Impact factor: 3.641

2. Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

Authors: Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal: Bioorg Med Chem Date: 2011-09-25 Impact factor: 3.641

Review 3. Thrombin and vascular inflammation.

Authors: Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal: Mol Cell Biochem Date: 2011-08-23 Impact factor: 3.396

Review 4. Drug therapy in haemodialysis patients. Special considerations in the elderly.

Authors: W L St Peter; J L Clark; O M Levos
Journal: Drugs Aging Date: 1998-06 Impact factor: 4.271

4 in total